Evidence map›Paper›PMID 21237494›Full record

ArticleHuman pathology2011

Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.

Huan-You Wang, Lily Jun-shen Huang, Zhaoli Liu, Rolando Garcia, Shiyong Li, Carlos A Galliani

Abstract readCase Reports
In one paragraph

Article in Human pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. TheFrontiers in oncology · 2026
    Article
  3. Autopsy findings of acute erythroid leukemia.Autopsy & case reports · 2023
    Article
  4. Erythroblastic sarcoma in the thoracic cavity of a cow.The Journal of veterinary medical science · 2019
    Article
  5. Myeloid Sarcoma Presented as Generalized Lymphadenopathy: Mimicking Malignant Lymphoma.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2018
    Article
  6. Article
  7. Article
  8. Myeloid sarcomas: a clinicopathologic study of 20 cases.Turkish journal of haematology : official journal of Turkish Society of Haematology · 2015
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Huan-You WangDepartment of Pathology, University of California San Diego Health Sciences, La Jolla, CA 92037-0987, USA. hywang2@ucsd.edu
Lily Jun-shen Huang
Zhaoli Liu
Rolando Garcia
Shiyong Li
Carlos A Galliani
The University of Texas Southwestern Medical Center · USCook Children's Medical Center · USEmory University · USUniversity of California, San Diego · US

Funding

JAK2 signaling in erythropoiesisR01HL089966 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI LILY JUNSHEN HUANG · 2007 to 2026
$7.4M
NHLBI NIH HHS R01 HL089966
6 · The paper itself

Abstract

Pure erythroid leukemia is a rare subtype of acute erythroid leukemia that is characterized by a predominant erythroid population, and erythroblastic sarcoma has not yet been described in the English literature. Here, we report a first case of erythroblastic sarcoma that presented as bilateral ovarian masses in a 3 ½-month-old infant girl with pure erythroid leukemia. Bone marrow aspirate and biopsy showed that the marrow was completely replaced by large-sized blasts consistent with erythroblasts. Immunophenotypically, both the tumor cells from the ovarian mass and bone marrow blasts were positive for CD117, glycophorin A, and hemoglobin A, demonstrating erythroid differentiation. Reverse transcriptase polymerase chain reaction showed that the tumor cells from ovarian mass expressed hemoglobin F and α1 spectrin, confirming their erythroid lineage. Conventional karyotype of the bone marrow aspirates revealed del(6)(q23q25) and trisomy 7 in all 21 cells examined. Fluorescence in situ hybridization of the ovarian mass demonstrated loss of c-myeloblastosis viral oncogene (C-MYB) at 6q23 locus in 41% of the cells, and deletion of chromosome 7 and 7q in 37% and 66% of cells, respectively. Taken together, we showed, for the first time, that pure erythroid leukemia presented as a myeloid sarcoma in the form of ovarian masses.

Indexed as

Bone MarrowCell LineChromosomes, Human, Pair 6Cytogenetic AnalysisErythroblastsFemaleFlow CytometryGene DeletionGenes, mybGlycophorinsHemoglobin AHumansImmunohistochemistryImmunophenotypingInfantIn Situ Hybridization, FluorescenceGlycophorinsHemoglobin AProto-Oncogene Proteins c-kit

Identifiers

PMID21237494
PMCPMC3078188
OpenAlexW1979736050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.